VERA Crossword

123456789101112131415161718
Across
  1. 1. Veterans Equitable Resource Allocation.
  2. 3. Patient ____ Process categorizes patients into specific classes based on clinical data and utilization factors.
  3. 7. Employee/collateral and _______ care is classified as nonreliant care and is not funded by VERA.
  4. 10. Process that identifies veterans who rely on VHA for their healthcare needs.
  5. 12. Data _____ ensures accuracy in data flow process by incorporating quality control processes that safeguard the data.
  6. 14. _____ Price Adjustment, accounts for local variations in cost of patient care.
  7. 15. An inpatient _______ within a 3-year period results in a fully vested veteran.
  8. 17. Every patient is equal to ____ PRP.
  9. 18. ___-year timeframe is used to identify basic care veteran population because these patients do not necessarily use VA healthcare services every year.
Down
  1. 2. Term that indicates funds are distributed fairly when patients receive care in more than one network. Hint: vEra
  2. 4. Allocation Resource Center, home of VERA.
  3. 5. Like the National Hurricane Center, VERA uses ________ methodology to predict the anticipated number of Complex Care patients based on historical data.
  4. 6. Pharmacy Benefits Management, provides clinical workload for VERA patient classification.
  5. 7. Method used to account for a veteran's care across different networks; each veteran equals a maximum value of 1.0.
  6. 8. ____ Cost Adjustment, provides additional funds for the most costly 1% of patients.
  7. 9. A veteran who has neither an inpatient admission nor a detailed medical evaluation with an appropriate CPT code by an appropriate provider within a 3-year period.
  8. 11. VERA also allocates funds for ______ and non-recurring maintenance.
  9. 13. Business _______, understanding of what it takes for a business to make or manage money and to produce desirable results.
  10. 16. ___ Payment Files identify payments to contracted and other non-VA providers considered by VERA.